Sign in

NCT06613568Recruiting

Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants

Prospective, Non-Randomized, Multicenter, Open-Label Study Evaluating the Use of the Moda-flx Hemodialysis System™ Under Professional Care and At Home by Participants With End Stage Kidney Disease (ESKD) Who Are on Stable Dialysis Regimens

Source: ClinicalTrials.gov · Last updated 6 Jul 2026

Brief summary (registry, in English)

The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
23 Sept 2024
Start date
6 Oct 2025
Primary completion date
Mar 2027
Lead sponsor
Diality Inc.
NCT number
NCT06613568

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 6 Oct 2025 to the primary completion date, Mar 2027
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Symptomatic intradialytic hypotension requiring medical intervention (ultrafiltration turned off, bolus of fluid) in at least two treatments during the Run-In period defined as:
    • Persistent pre-dialysis sitting SBP \< 100 mmHg despite medical therapy,
    • Nadir intradialytic Systolic Blood Pressure (SBP) \< 90 mmHg, if Subject's pre-HD SBP \< 160 mmHg
    • Nadir intradialytic SBP \< 100 mmHg if Subject's pre-HD SBP ≥ 160 mmHg
  • Participant had an average ultrafiltration rate \> 13 mL/kg/hour during the last 2 weeks prior to Screening, per medical records.
  • Had a significant cardiovascular adverse event within the last 90 days prior to Screening.

Other illness

  • Documented history of non-adherence to dialysis therapy that would prevent successful completion of the study

Lab values

  • Hgb level of \< 9 g/dL at Screening

Who the study is looking for

  • Are between 18 and 80 years of age and Care Partner is at least 18 years of age at the time of signing consent.
  • Have a diagnosis of end stage kidney disease (ESKD) adequately treated by maintenance dialysis (defined as achieving a spKt/V ≥ 1.2 OR stdKt/V ≥ 2.1) and be deemed stable by their treating nephrologist prior to the end of the Screening Period
  • Have a well-functioning and stable vascular access (tunneled central venous catheter arteriovenous fistula, or graft) that allows a blood flow of at least 300 ml/min prior to the end of Screening
  • Can successfully complete a Skills and Comprehension Assessment with a Care Partner prior to the completion of the Training Period.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
aQua Research Institute, LLC
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting
Nephrology Associates of Knoxville
Coordinator of this site? Confirm its status
KnoxvilleUnited StatesRecruiting
New York Kidney Hypertension Medicine
Coordinator of this site? Confirm its status
New Hyde ParkUnited StatesRecruiting
North America Research Institute
Coordinator of this site? Confirm its status
San DimasUnited StatesRecruiting
University of Washington
Coordinator of this site? Confirm its status
SeattleUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.